Inclusion Criteria:  Fully vaccinated against COVID-19 (participant has received his/her final dose at least one month prior to the screening visit). Individuals who regularly exercise as per physical activity guidelines for Americans10 [(structured or unstructured exercise for a minimum of 150 cumulative minutes per week (low-end) to 500 cumulative minutes of exercise per week (high-end)]) and willing to maintain the same level of physical activity throughout the study period. Healthy individuals between 18 to 40 years of age (inclusive). Individuals with BMI in the range of 18.5-34.9 (inclusive). Good health as determined by medical history and cleared for exercise as assessed by the PI. Males and females of reproductive potential willing to use double-barrier to avoid pregnancy and sexually transmitted infection (STI) during the study period. Provide signed and dated informed consent form. Willing and able to comply with the protocol.  Exclusion Criteria:  Participants with existing musculoskeletal injuries that would prevent full participation, or a history of autoimmune disease or diabetes. History of clinically significant cardiovascular, respiratory, renal, cerebrovascular, metabolic, pulmonary, gastrointestinal, neurological, hematological, autoimmune, lymphatic, psychiatric, hepatobiliary or endocrine disorders, including individuals with Type I or Type II diabetes, or other clinically significant medical condition that, in the opinion of the investigator, may preclude safe study participation. Females who are pregnant or lactating or planning on becoming pregnant during the course of the study. Participants using blood thinning medications or supplements. Have a known sensitivity or allergy to any of the study products or its excipients. Participants who develop a cold or other acute upper respiratory tract infections or influenza or any other major illness during the course of study which may compromise participants ability to complete study procedures or affect study outcomes. Participating or has participated in another research study within 30 days prior to the study screening visit in which another study product has been consumed. Participants with current or past medical history of long-term COVID-19 symptoms (remained symptomatic for at least 2 weeks or more). Professional athletes, collegiate athletes, competitive body builders or those who compete at the elite category within their sport. Any condition or abnormality that, in the opinion of the investigator, would compromise the safety of the participant or the quality of the study data.